Annual CFF
$10.59 M
+$10.59 M+165421.88%
31 December 2023
Summary:
Genprex annual cash flow from financing activities is currently $10.59 million, with the most recent change of +$10.59 million (+165421.88%) on 31 December 2023. During the last 3 years, it has fallen by -$31.00 million (-74.53%). GNPX annual CFF is now -74.53% below its all-time high of $41.59 million, reached on 31 December 2020.GNPX Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFF
$1.22 M
+$1.19 M+5742.31%
30 September 2024
Summary:
Genprex quarterly cash flow from financing activities is currently $1.22 million, with the most recent change of +$1.19 million (+5742.31%) on 30 September 2024. Over the past year, it has dropped by -$5.30 million (-81.34%). GNPX quarterly CFF is now -95.28% below its all-time high of $25.73 million, reached on 31 March 2020.GNPX Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFF
$8.03 M
-$5.30 M-39.75%
30 September 2024
Summary:
Genprex TTM cash flow from financing activities is currently $8.03 million, with the most recent change of -$5.30 million (-39.75%) on 30 September 2024. Over the past year, it has dropped by -$2.57 million (-24.24%). GNPX TTM CFF is now -80.69% below its all-time high of $41.59 million, reached on 31 December 2020.GNPX TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
GNPX Cash From Financing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +10000.0% | -81.3% | -24.2% |
| 3 y3 years | -74.5% | +399.1% | -79.0% |
| 5 y5 years | -31.2% | +100.0% | +1826.4% |
GNPX Cash From Financing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -74.5% | >+9999.0% | -82.1% | -79.0% | >+9999.0% | |
| 5 y | 5 years | -74.5% | >+9999.0% | -95.3% | -80.7% | >+9999.0% | |
| alltime | all time | -74.5% | >+9999.0% | -95.3% | +665.7% | -80.7% |
Genprex Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $1.22 M(+5742.3%) | $8.03 M(-39.8%) |
| June 2024 | - | $20.80 K(-99.7%) | $13.33 M(+0.2%) |
| Mar 2024 | - | $6.79 M(>+9900.0%) | $13.31 M(+25.6%) |
| Dec 2023 | $10.59 M(>+9900.0%) | $0.00(-100.0%) | $10.59 M(-0.0%) |
| Sept 2023 | - | $6.51 M(>+9900.0%) | $10.60 M(+159.3%) |
| June 2023 | - | $0.00(-100.0%) | $4.09 M(0.0%) |
| Mar 2023 | - | $4.08 M(>+9900.0%) | $4.09 M(>+9900.0%) |
| Dec 2022 | $6400.00(-100.0%) | $4700.00(+161.1%) | $6500.00(+261.1%) |
| Sept 2022 | - | $1800.00(>+9900.0%) | $1800.00(-99.3%) |
| June 2022 | - | $0.00(0.0%) | $243.50 K(-31.1%) |
| Mar 2022 | - | $0.00(0.0%) | $353.50 K(-98.6%) |
| Dec 2021 | $25.68 M(-38.3%) | $0.00(-100.0%) | $25.68 M(-32.7%) |
| Sept 2021 | - | $243.50 K(+121.4%) | $38.17 M(-1.4%) |
| June 2021 | - | $110.00 K(-99.6%) | $38.72 M(-6.0%) |
| Mar 2021 | - | $25.32 M(+102.7%) | $41.18 M(-1.0%) |
| Dec 2020 | $41.59 M | $12.49 M(+1474.5%) | $41.59 M(+37.0%) |
| Sept 2020 | - | $793.60 K(-69.1%) | $30.36 M(+2.7%) |
| June 2020 | - | $2.57 M(-90.0%) | $29.57 M(+9.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2020 | - | $25.73 M(+1930.6%) | $27.00 M(+2030.6%) |
| Dec 2019 | $1.27 M(-91.8%) | $1.27 M(>+9900.0%) | $1.27 M(+204.0%) |
| Sept 2019 | - | $0.00(0.0%) | $416.80 K(+106.3%) |
| June 2019 | - | $0.00(0.0%) | $202.00 K(-98.7%) |
| Mar 2019 | - | $0.00(-100.0%) | $15.31 M(-0.5%) |
| Dec 2018 | $15.39 M(+1838.2%) | $416.80 K(-294.0%) | $15.39 M(+2.8%) |
| Sept 2018 | - | -$214.80 K(-101.4%) | $14.97 M(-5.0%) |
| June 2018 | - | $15.11 M(>+9900.0%) | $15.75 M(+1707.7%) |
| Mar 2018 | - | $77.40 K(>+9900.0%) | $871.40 K(+9.7%) |
| Dec 2017 | $794.00 K(-70.7%) | $0.00(-100.0%) | $794.00 K(-65.4%) |
| Sept 2017 | - | $565.00 K(+146.7%) | $2.29 M(-20.6%) |
| June 2017 | - | $229.00 K(>+9900.0%) | $2.89 M(+6.8%) |
| Mar 2017 | - | $0.00(-100.0%) | $2.71 M(0.0%) |
| Dec 2016 | $2.71 M(+273.3%) | $1.50 M(+29.2%) | $2.71 M(+124.4%) |
| Sept 2016 | - | $1.16 M(+2479.8%) | $1.21 M(+2579.8%) |
| June 2016 | - | $45.00 K(>+9900.0%) | $45.00 K(>+9900.0%) |
| Mar 2016 | - | $0.00 | $0.00 |
| Dec 2015 | $724.90 K | - | - |
FAQ
- What is Genprex annual cash flow from financing activities?
- What is the all time high annual CFF for Genprex?
- What is Genprex annual CFF year-on-year change?
- What is Genprex quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Genprex?
- What is Genprex quarterly CFF year-on-year change?
- What is Genprex TTM cash flow from financing activities?
- What is the all time high TTM CFF for Genprex?
- What is Genprex TTM CFF year-on-year change?
What is Genprex annual cash flow from financing activities?
The current annual CFF of GNPX is $10.59 M
What is the all time high annual CFF for Genprex?
Genprex all-time high annual cash flow from financing activities is $41.59 M
What is Genprex annual CFF year-on-year change?
Over the past year, GNPX annual cash flow from financing activities has changed by +$10.59 M (+165421.88%)
What is Genprex quarterly cash flow from financing activities?
The current quarterly CFF of GNPX is $1.22 M
What is the all time high quarterly CFF for Genprex?
Genprex all-time high quarterly cash flow from financing activities is $25.73 M
What is Genprex quarterly CFF year-on-year change?
Over the past year, GNPX quarterly cash flow from financing activities has changed by -$5.30 M (-81.34%)
What is Genprex TTM cash flow from financing activities?
The current TTM CFF of GNPX is $8.03 M
What is the all time high TTM CFF for Genprex?
Genprex all-time high TTM cash flow from financing activities is $41.59 M
What is Genprex TTM CFF year-on-year change?
Over the past year, GNPX TTM cash flow from financing activities has changed by -$2.57 M (-24.24%)